Tau Therapeutics' Private Equity - III Round

Tau Therapeutics raised a round of funding on June 10, 2014.

Tau Therapeutics is a clinical stage company developing oncology drugs for solid tumors that selectively inhibit the T-type calcium channel - a mechanism of action for cancer. The company's approach, …

Articles about Tau Therapeutics' Private Equity - III Round: